🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

14 recruiting trials

for Dravet Syndrome

ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome NCT07531745Phase 1, Phase 26 sites📍 Ann Arbor📍 Rochester📍 Durham Ionis Pharmaceuticals, Inc. · Tests: ION337 A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome NCT04462770Phase 368 sites📍 Birmingham📍 Little Rock📍 Los Angeles Epygenix · Tests: Clemizole HCl, Placebo Multicentre Real-life Follow-up Study of Rare Epileptic Syndromes in Children and Adolescents NCT05126914n/a11 sites📍 Angers📍 Bordeaux📍 Brest Assistance Publique - Hôpitaux de Paris A Study to Evaluate the Safety and Pharmacokinetics of RC001 in Children With Dravet Syndrome NCT07675746EARLY Phase 11 site📍 Guangzhou Second Affiliated Hospital of Guangzhou Medical University · Tests: RC001 injection-Dose Escalation Cohort, RC001 injection-Fixed Dose Cohort A PET-MRI Study of Serotoninergic Brainstem Pathway in Patients With Dravet Syndrome NCT07013331NA1 site📍 Bron Hospices Civils de Lyon · Tests: [18F]MPPF PET-MRI A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome NCT05419492Phase 1, Phase 214 sites📍 San Francisco📍 Aurora📍 Miami Encoded Therapeutics · Tests: ETX101 BMB-101 in Absence Epilepsy and DEE NCT06401538Phase 25 sites📍 Randwick📍 Herston📍 Fitzroy Bright Minds Biosciences Pty Ltd · Tests: BMB-101 Registry and Natural History of Epilepsy-Dyskinesia Syndromes NCT06967727n/a1 site📍 Boston Boston Children's Hospital Assessment of Safety of the Use of Fenfluramine in Children With Dravet Syndrome Under 24 Months of Age NCT06598449Phase 41 site📍 Aurora University of Colorado, Denver · Tests: fenfluramine International CDKL5 Clinical Research Network NCT05558371n/a9 sites📍 Los Angeles📍 Aurora📍 Boston University of Colorado, Denver · Tests: No intervention. The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome Project NCT07112365Phase 41 site📍 Houston The University of Texas Health Science Center, Houston · Tests: Fenfluramine treatment (Fintepla), Hypercapnia Challenge using the device (RespirAct) GABA Biomarkers in Dravet Syndrome NCT05651204n/a1 site📍 Fort Worth Cook Children's Health Care System · Tests: GABA Blood Level Longitudinal Study of Phenotypic and Developmental Severity in Patients With Dravet Syndrome With SCN1A Gene Mutation NCT07251673n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes NCT06585605n/a1 site📍 Boston Boston Children's Hospital
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy